Top compounds associated with response to CDKN2D


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 9e-05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA BMS-754807 GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA Lisitinib GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA clofarabine CTRPv2 pan-cancer AAC 0.11 0.0002
mRNA Docetaxel gCSI pan-cancer AAC -0.2 0.0002
mRNA thapsigargin gCSI pan-cancer AAC -0.21 0.0002
Download CSV